Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRY | BVS | RLMD | ||
| Company | Ars Pharmaceuticals Inc | Bioventus Inc Cl A | Relmada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.25 | 10.01 | 7.21 | ||
| High | 8.45 | 10.24 | 7.59 | ||
| Low | 7.93 | 9.71 | 6.89 | ||
| Latest | 7.95 | 10.01 | 7.03 | ||
| Change | -0.34 | -0.08 | -0.18 | ||
| % Change | -4.10% | -0.79% | -2.50% | ||
| Volume | 2,009,700 | 324,200 | 1,416,500 | ||
| 20-Day Average Volume | 1,560,870 | 460,860 | 1,426,450 | ||
| Previous Close | 8.29 | 10.09 | 7.21 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.14 | 9.58 | 7.11 | ||
| 20-Day Raw Stochastic | 27.38% | 64.62% | 45.35% | ||
| 20-Day Relative Strength | 44.01 | 58.71 | 56.39 | ||
| Weighted Alpha | -48.64 | +49.41 | +482.44 | ||
| Today's Opinion | 100% Sell | 100% Buy | 88% Buy | ||
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.81% since 04/20/26 | -2.63% since 04/20/26 | -4.61% since 04/20/26 | ||
| Low | 7.75 on 04/21/26 | 9.54 on 04/23/26 | 6.86 on 04/21/26 | ||
| High | 8.56 on 04/22/26 | 10.46 on 04/21/26 | 7.59 on 04/27/26 | ||
| 1-Month | |||||
| %Chg | -1.49% since 03/27/26 | +11.97% since 03/27/26 | +9.33% since 03/27/26 | ||
| Low | 7.72 on 04/02/26 | 8.64 on 03/31/26 | 6.28 on 03/30/26 | ||
| High | 8.56 on 04/22/26 | 10.76 on 04/17/26 | 7.94 on 04/10/26 | ||
| 3-Month | |||||
| %Chg | -24.57% since 01/27/26 | +26.39% since 01/27/26 | +71.46% since 01/27/26 | ||
| Low | 7.20 on 03/24/26 | 7.59 on 01/29/26 | 3.22 on 02/04/26 | ||
| High | 10.74 on 02/03/26 | 10.76 on 04/17/26 | 7.94 on 04/10/26 | ||
| 6-Month | |||||
| %Chg | -16.84% since 10/27/25 | +49.18% since 10/27/25 | +201.72% since 10/27/25 | ||
| Low | 6.66 on 11/21/25 | 6.47 on 11/21/25 | 2.15 on 11/03/25 | ||
| High | 13.15 on 01/12/26 | 10.76 on 04/17/26 | 7.94 on 04/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 823,172 | 839,034 | 756,243 | ||
| Shares Outstanding, K | 99,297 | 83,155 | 104,888 | ||
| Annual Sales | 84,280,000 | 568,090,000 | 0 | ||
| Annual Net Income | -171,300,000 | 22,730,000 | -57,390,000 | ||
| Last Quarter Sales | 28,090,000 | 157,900,000 | 0 | ||
| Last Quarter Net Income | -41,320,000 | 14,760,000 | -19,870,000 | ||
| 60-Month Beta | 0.86 | 0.70 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.42 on 03/09/26 | 0.24 on 03/05/26 | -0.27 on 03/19/26 | ||
| Earnings Date | 05/13/26 | 05/05/26 | 05/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.28 | 0.00 | ||